734 related articles for article (PubMed ID: 21080925)
1. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.
Liu Y; Mu R; Wang S; Long L; Liu X; Li R; Sun J; Guo J; Zhang X; Guo J; Yu P; Li C; Liu X; Huang Z; Wang D; Li H; Gu Z; Liu B; Li Z
Arthritis Res Ther; 2010; 12(6):R210. PubMed ID: 21080925
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis.
Ma D; Xu K; Zhang G; Liu Y; Gao J; Tian M; Wei C; Li J; Zhang L
Int Immunopharmacol; 2019 Sep; 74():105687. PubMed ID: 31295689
[TBL] [Abstract][Full Text] [Related]
3. Bone Marrow Mesenchymal Stem Cells Decrease the Expression of RANKL in Collagen-Induced Arthritis Rats via Reducing the Levels of IL-22.
Li F; Li X; Liu G; Gao C; Li X
J Immunol Res; 2019; 2019():8459281. PubMed ID: 31828174
[TBL] [Abstract][Full Text] [Related]
4. [Role of galectin-1 in regulation of umbilical cord mesenchymal stem cells on T cells of rheumatoid arthritis].
Sun L; An Z; Li CH; Liu R; Zhao JX; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):964-969. PubMed ID: 27987498
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA/1 mice with collagen-induced arthritis.
Yu Y; Yoon KA; Kang TW; Jeon HJ; Sim YB; Choe SH; Baek SY; Lee S; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Jul; 13(7):1134-1142. PubMed ID: 30959558
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes.
Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L
Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817
[TBL] [Abstract][Full Text] [Related]
7. Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?
De Bari C
Arthritis Res Ther; 2015 May; 17(1):113. PubMed ID: 25929877
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
9. Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts.
Zhu W; Meng L; Jiang C; He X; Hou W; Xu P; Du H; Holmdahl R; Lu S
Arthritis Res Ther; 2011 Jun; 13(3):R103. PubMed ID: 21708001
[TBL] [Abstract][Full Text] [Related]
10. The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis.
Miranda JP; Camões SP; Gaspar MM; Rodrigues JS; Carvalheiro M; Bárcia RN; Cruz P; Cruz H; Simões S; Santos JM
Front Immunol; 2019; 10():18. PubMed ID: 30804924
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Collagen-Induced Arthritis Using Immune Modulatory Properties of Human Mesenchymal Stem Cells.
Park KH; Mun CH; Kang MI; Lee SW; Lee SK; Park YB
Cell Transplant; 2016; 25(6):1057-72. PubMed ID: 25853338
[TBL] [Abstract][Full Text] [Related]
15. Nitidine chloride inhibits fibroblast like synoviocytes-mediated rheumatoid synovial inflammation and joint destruction by targeting KCNH1.
Shen C; Kuang Y; Xu S; Li R; Wang J; Zou Y; Wang C; Xu S; Liang L; Lin C; Xiao Y; Xu H
Int Immunopharmacol; 2021 Dec; 101(Pt A):108273. PubMed ID: 34700130
[TBL] [Abstract][Full Text] [Related]
16. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation.
Chen M; Su W; Lin X; Guo Z; Wang J; Zhang Q; Brand D; Ryffel B; Huang J; Liu Z; He X; Le AD; Zheng SG
Arthritis Rheum; 2013 May; 65(5):1181-93. PubMed ID: 23400582
[TBL] [Abstract][Full Text] [Related]
20. Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model via enhanced TGF-β1 production.
Choi EW; Lim IR; Park JH; Song J; Choi B; Kim S
Stem Cell Res Ther; 2023 Oct; 14(1):283. PubMed ID: 37794417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
